{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:50:58Z","timestamp":1791813058210,"version":"4.3.4"},"reference-count":34,"publisher":"e-Century Publishing Corporation","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Cancer Res"],"DOI":"10.62347\/jphf4071","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T23:16:03Z","timestamp":1712272563000},"page":"996-1014","source":"Crossref","is-referenced-by-count":6,"title":["Comprehensive analysis identifies long non-coding RNA RNASEH1-AS1 as a potential prognostic biomarker and oncogenic target in hepatocellular carcinoma"],"prefix":"10.62347","volume":"14","author":[{"given":"Jin","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71: 209-249.","journal-title":"CA Cancer J Clin"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1053\/j.gastro.2023.01.033","article-title":"Global epidemiology and genetics of hepatocellular carcinoma","volume":"164","author":"Toh","year":"2023","unstructured":"Toh MR, Wong EYT, Wong SH, Ng AWT, Loo LH, Chow PK and Ngeow J. Global epidemiology and genetics of hepatocellular carcinoma. Gastroenterology 2023; 164: 766-782.","journal-title":"Gastroenterology"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"781820","DOI":"10.3389\/fonc.2022.781820","article-title":"Clinical applications of liquid biopsy in hepatocellular carcinoma","volume":"12","author":"Yang","year":"2022","unstructured":"Yang JC, Hu JJ, Li YX, Luo W, Liu JZ and Ye DW. Clinical applications of liquid biopsy in hepatocellular carcinoma. Front Oncol 2022; 12: 781820.","journal-title":"Front Oncol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.hpb.2020.10.031","article-title":"Treatment strategies for early stage hepatocellular carcinoma: a systematic review and network meta-analysis of randomised clinical trials","volume":"23","author":"Kamarajah","year":"2021","unstructured":"Kamarajah SK, Bundred JR, Littler P, Reeves H, Manas DM and White SA. Treatment strategies for early stage hepatocellular carcinoma: a systematic review and network meta-analysis of randomised clinical trials. HPB (Oxford) 2021; 23: 495-505.","journal-title":"HPB (Oxford)"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"802","DOI":"10.20892\/j.issn.2095-3941.2021.0661","article-title":"The advanced development of molecular targeted therapy for hepatocellular carcinoma","volume":"19","author":"Yan","year":"2022","unstructured":"Yan T, Yu L, Zhang N, Peng C, Su G, Jing Y, Zhang L, Wu T, Cheng J, Guo Q, Shi X and Lu Y. The advanced development of molecular targeted therapy for hepatocellular carcinoma. Cancer Biol Med 2022; 19: 802-817.","journal-title":"Cancer Biol Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"896752","DOI":"10.3389\/fimmu.2022.896752","article-title":"Advances in immune checkpoint inhibitors for advanced hepatocellular carcinoma","volume":"13","author":"Chen","year":"2022","unstructured":"Chen Y, Hu H, Yuan X, Fan X and Zhang C. Advances in immune checkpoint inhibitors for advanced hepatocellular carcinoma. Front Immunol 2022; 13: 896752.","journal-title":"Front Immunol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.3748\/wjg.v29.i6.1054","article-title":"Immunotherapy for hepatocellular carcinoma: current status and future perspectives","volume":"29","author":"DS","year":"2023","unstructured":"Mandlik DS, Mandlik SK and Choudhary HB. Immunotherapy for hepatocellular carcinoma: current status and future perspectives. World J Gastroenterol 2023; 29: 1054-1075.","journal-title":"World J Gastroenterol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","article-title":"Long non-coding RNAs: definitions, functions, challenges and recommendations","volume":"24","author":"Mattick","year":"2023","unstructured":"Mattick JS, Amaral PP, Carninci P, Carpenter S, Chang HY, Chen LL, Chen R, Dean C, Dinger ME, Fitzgerald KA, Gingeras TR, Guttman M, Hirose T, Huarte M, Johnson R, Kanduri C, Kapranov P, Lawrence JB, Lee JT, Mendell JT, Mercer TR, Moore KJ, Nakagawa S, Rinn JL, Spector DL, Ulitsky I, Wan Y, Wilusz JE and Wu M. Long non-coding RNAs: definitions, functions, challenges and recommendations. Nat Rev Mol Cell Biol 2023; 24: 430-447.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","article-title":"Gene regulation by long non-coding RNAs and its biological functions","volume":"22","author":"Statello","year":"2021","unstructured":"Statello L, Guo CJ, Chen LL and Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol 2021; 22: 96-118.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1123975","DOI":"10.3389\/fcell.2023.1123975","article-title":"Behind the scenes: how RNA orchestrates the epigenetic regulation of gene expression","volume":"11","author":"Mangiavacchi","year":"2023","unstructured":"Mangiavacchi A, Morelli G and Orlando V. Behind the scenes: how RNA orchestrates the epigenetic regulation of gene expression. Front Cell Dev Biol 2023; 11: 1123975.","journal-title":"Front Cell Dev Biol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"612393","DOI":"10.3389\/fmed.2020.612393","article-title":"Long non-coding RNAs in cancer: implications for diagnosis, prognosis, and therapy","volume":"7","author":"Qian","year":"2020","unstructured":"Qian Y, Shi L and Luo Z. Long non-coding RNAs in cancer: implications for diagnosis, prognosis, and therapy. Front Med (Lausanne) 2020; 7: 612393.","journal-title":"Front Med (Lausanne)"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3390\/bioengineering9080406","article-title":"Function of the long noncoding RNAs in hepatocellular carcinoma: classification, molecular mechanisms, and significant therapeutic potentials","volume":"9","author":"Khan","year":"2022","unstructured":"Khan A and Zhang X. Function of the long noncoding RNAs in hepatocellular carcinoma: classification, molecular mechanisms, and significant therapeutic potentials. Bioengineering (Basel) 2022; 9: 406.","journal-title":"Bioengineering (Basel)"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"121751","DOI":"10.1016\/j.lfs.2023.121751","article-title":"Role of lncRNAs in hepatocellular carcinoma","volume":"325","author":"Verma","year":"2023","unstructured":"Verma S, Sahu BD and Mugale MN. Role of lncRNAs in hepatocellular carcinoma. Life Sci 2023; 325: 121751.","journal-title":"Life Sci"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"154604","DOI":"10.1016\/j.prp.2023.154604","article-title":"Long non-coding RNAs in hepatocellular carcinoma","volume":"248","author":"WJ","year":"2023","unstructured":"Ge WJ, Huang H, Wang T, Zeng WH, Guo M, Ren CR, Fan TY, Liu F and Zeng X. Long non-coding RNAs in hepatocellular carcinoma. Pathol Res Pract 2023; 248: 154604.","journal-title":"Pathol Res Pract"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Wang Y, Yang F and Zhuang Y. Identification of a progression-associated long non-coding RNA signature for predicting the prognosis of lung squamous cell carcinoma. Exp Ther Med 2018; 15: 1185-1192.","DOI":"10.3892\/etm.2017.5571"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"607722","DOI":"10.3389\/fgene.2020.607722","article-title":"Identification of potential prognostic competing triplets in high-grade serous ovarian cancer","volume":"11","author":"Zhao","year":"2020","unstructured":"Zhao J, Song X, Xu T, Yang Q, Liu J, Jiang B and Wu J. Identification of potential prognostic competing triplets in high-grade serous ovarian cancer. Front Genet 2020; 11: 607722.","journal-title":"Front Genet"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1002\/cam4.4509","article-title":"Long noncoding RNASEH1-AS1 exacerbates the progression of non-small cell lung cancer by acting as a ceRNA to regulate microRNA-516a-5p\/FOXK1 and thereby activating the Wnt\/beta-catenin signaling pathway","volume":"11","author":"Zhang","year":"2022","unstructured":"Zhang C, Huang J, Lou K and Ouyang H. Long noncoding RNASEH1-AS1 exacerbates the progression of non-small cell lung cancer by acting as a ceRNA to regulate microRNA-516a-5p\/FOXK1 and thereby activating the Wnt\/beta-catenin signaling pathway. Cancer Med 2022; 11: 1589-1604.","journal-title":"Cancer Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1261\/rna.060814.117","article-title":"LncATLAS database for subcellular localization of long noncoding RNAs","volume":"23","author":"Mas-Ponte","year":"2017","unstructured":"Mas-Ponte D, Carlevaro-Fita J, Palumbo E, Hermoso Pulido T, Guigo R and Johnson R. LncATLAS database for subcellular localization of long noncoding RNAs. RNA 2017; 23: 1080-1087.","journal-title":"RNA"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"Hanzelmann","year":"2013","unstructured":"Hanzelmann S, Castelo R and Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics 2013; 14: 7.","journal-title":"BMC Bioinformatics"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"963689720986071","DOI":"10.1177\/0963689720986071","article-title":"LncRNA PCAT1 interacts with DKC1 to regulate proliferation, invasion and apoptosis in NSCLC cells via the VEGF\/AKT\/Bcl2\/Caspase9 pathway","volume":"30","author":"Liu","year":"2021","unstructured":"Liu SY, Zhao ZY, Qiao Z, Li SM and Zhang WN. LncRNA PCAT1 interacts with DKC1 to regulate proliferation, invasion and apoptosis in NSCLC cells via the VEGF\/AKT\/Bcl2\/Caspase9 pathway. Cell Transplant 2021; 30: 963689720986071.","journal-title":"Cell Transplant"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"8885","DOI":"10.1080\/21655979.2021.1988366","article-title":"Pseudogene fms-related tyrosine kinase 1 pseudogene 1 (FLT1P1) cooperates with RNA binding protein dyskeratosis congenita 1 (DKC1) to restrain trophoblast cell proliferation and angiogenesis by targeting fms-related tyrosine kinase 1 (FLT1) in preeclampsia","volume":"12","author":"Chi","year":"2021","unstructured":"Chi Z, Sun Y, Yu Z, Zhou F, Wang H and Zhang M. Pseudogene fms-related tyrosine kinase 1 pseudogene 1 (FLT1P1) cooperates with RNA binding protein dyskeratosis congenita 1 (DKC1) to restrain trophoblast cell proliferation and angiogenesis by targeting fms-related tyrosine kinase 1 (FLT1) in preeclampsia. Bioengineered 2021; 12: 8885-8897.","journal-title":"Bioengineered"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ajg.2022.10.013","article-title":"3 promotes the progression of colon cancer by recruiting DKC1 to stabilize CTNNB1","volume":"24","author":"Tang","year":"2023","unstructured":"Tang H, Dou Y, Meng Y, Lu Q and Liang L. AC125611.3 promotes the progression of colon cancer by recruiting DKC1 to stabilize CTNNB1. Arab J Gastroenterol 2023; 24: 155-162.","journal-title":"Arab J Gastroenterol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, Lencioni R, Koike K, Zucman-Rossi J and Finn RS. Hepatocellular carcinoma. Nat Rev Dis Primers 2021; 7: 6.","journal-title":"Nat Rev Dis Primers"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"113327","DOI":"10.1016\/j.biopha.2022.113327","article-title":"Emerging roles and potential clinical applications of long non-coding RNAs in hepatocellular carcinoma","volume":"153","author":"Sheng","year":"2022","unstructured":"Sheng J, Lv E, Xia L and Huang W. Emerging roles and potential clinical applications of long non-coding RNAs in hepatocellular carcinoma. Biomed Pharmacother 2022; 153: 113327.","journal-title":"Biomed Pharmacother"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3390\/cells11020222","article-title":"Plasmacytoid dendritic cells and cancer immunotherapy","volume":"11","author":"Fu","year":"2022","unstructured":"Fu C, Zhou L, Mi QS and Jiang A. Plasmacytoid dendritic cells and cancer immunotherapy. Cells 2022; 11: 222.","journal-title":"Cells"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40364-023-00460-1","article-title":"Roles and mechanisms of tumour-infiltrating B cells in human cancer: a new force in immunotherapy","volume":"11","author":"Zhang","year":"2023","unstructured":"Zhang E, Ding C, Li S, Zhou X, Aikemu B, Fan X, Sun J, Zheng M and Yang X. Roles and mechanisms of tumour-infiltrating B cells in human cancer: a new force in immunotherapy. Biomark Res 2023; 11: 28.","journal-title":"Biomark Res"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.stem.2016.01.024","article-title":"Divergent lncRNAs regulate gene expression and lineage differentiation in pluripotent cells","volume":"18","author":"Luo","year":"2016","unstructured":"Luo S, Lu JY, Liu L, Yin Y, Chen C, Han X, Wu B, Xu R, Liu W, Yan P, Shao W, Lu Z, Li H, Na J, Tang F, Wang J, Zhang YE and Shen X. Divergent lncRNAs regulate gene expression and lineage differentiation in pluripotent cells. Cell Stem Cell 2016; 18: 637-652.","journal-title":"Cell Stem Cell"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Wu H, Sun H, Liang X, Lima WF and Crooke ST. Human RNase H1 is associated with protein P32 and is involved in mitochondrial pre-rRNA processing. PLoS One 2013; 8: e71006.","DOI":"10.1371\/journal.pone.0071006"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Lopez-Canovas JL, Herman-Sanchez N, Moreno-Montilla MT, Del Rio-Moreno M, Alors-Perez E, Sanchez-Frias ME, Amado V, Ciria R, Briceno J, de la Mata M, Castano JP, Rodriguez-Peralvarez M, Luque RM and Gahete MD. Spliceosomal profiling identifies EIF4A3 as a novel oncogene in hepatocellular carcinoma acting through the modulation of FGFR4 splicing. Clin Transl Med 2022; 12: e1102.","DOI":"10.1002\/ctm2.1102"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.2147\/CMAR.S176268","article-title":"Identification of WDR12 as a novel oncogene involved in hepatocellular carcinoma propagation","volume":"10","author":"Yin","year":"2018","unstructured":"Yin Y, Zhou L, Zhan R, Zhang Q and Li M. Identification of WDR12 as a novel oncogene involved in hepatocellular carcinoma propagation. Cancer Manag Res 2018; 10: 3985-3993.","journal-title":"Cancer Manag Res"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Liu B, Zhang J, Huang C and Liu H. Dyskerin overexpression in human hepatocellular carcinoma is associated with advanced clinical stage and poor patient prognosis. PLoS One 2012; 7: e43147.","DOI":"10.1371\/journal.pone.0043147"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41420-023-01355-8","article-title":"Role of NAT10-mediated ac4C-modified HSP90AA1 RNA acetylation in ER stress-mediated metastasis and lenvatinib resistance in hepatocellular carcinoma","volume":"9","author":"Pan","year":"2023","unstructured":"Pan Z, Bao Y, Hu M, Zhu Y, Tan C, Fan L, Yu H, Wang A, Cui J and Sun G. Role of NAT10-mediated ac4C-modified HSP90AA1 RNA acetylation in ER stress-mediated metastasis and lenvatinib resistance in hepatocellular carcinoma. Cell Death Discov 2023; 9: 56.","journal-title":"Cell Death Discov"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.cell.2014.08.028","article-title":"Transcriptome-wide mapping reveals widespread dynamic-regulated pseudouridylation of ncRNA and mRNA","volume":"159","author":"Schwartz","year":"2014","unstructured":"Schwartz S, Bernstein DA, Mumbach MR, Jovanovic M, Herbst RH, Leon-Ricardo BX, Engreitz JM, Guttman M, Satija R, Lander ES, Fink G and Regev A. Transcriptome-wide mapping reveals widespread dynamic-regulated pseudouridylation of ncRNA and mRNA. Cell 2014; 159: 148-162.","journal-title":"Cell"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nchembio.1836","article-title":"Chemical pulldown reveals dynamic pseudouridylation of the mammalian transcriptome","volume":"11","author":"Li","year":"2015","unstructured":"Li X, Zhu P, Ma S, Song J, Bai J, Sun F and Yi C. Chemical pulldown reveals dynamic pseudouridylation of the mammalian transcriptome. Nat Chem Biol 2015; 11: 592-597.","journal-title":"Nat Chem Biol"}],"container-title":["American Journal of Cancer Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajcr\/14\/3\/ajcr0152190.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:52:13Z","timestamp":1766022733000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajcr\/14\/3\/ajcr0152190.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.62347\/jphf4071","relation":{},"ISSN":["2156-6976"],"issn-type":[{"value":"2156-6976","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]}}}